CD4 T‐cell epitopes of human α B‐crystallin

Of potential importance to multiple sclerosis (MS), oligodendroglial α B‐crystallin is expressed and associated with the myelin sheath at the earliest stage of MS lesion development. We selected T‐cell lines specific for human α B‐crystallin from peripheral blood mononuclear cells (PBMC) of HLA‐DR2 homozygous MS patients and found that the α B‐crystallin‐specific T‐cells were CD4+ and restricted by DRB1*1501, and expressed Th1 cytokines. The CD4 T‐cell epitopes of human α B‐crystallin were determined by proliferation of α B‐crystallin‐specific T‐cell lines to 17 20‐mer synthetic overlapping peptides spanning the entire molecule of human α B‐crystallin. It was found that the HLA‐DR2 donor‐derived α B‐crystallin‐specific T‐cell lines proliferated to α B‐crystallin peptides 21–40, 41–60, and to a lesser extent, 131–150. These T‐cell proliferation responses were associated with intracellular expression of interleukin‐2 (IL‐2) and secretion of interferon‐γ (IFN‐γ), and tumor necrosis factor‐α (TNF‐α). The amino acid sequences of these peptides were compatible with predicted HLA‐DR2‐restricted binding motifs. PBMC of an early active MS patient proliferated to the epitope‐containing peptides significantly better than did those of later stage MS patients or healthy controls. Taken together, these findings suggest that autoreactive α B‐crystallin‐specific Th1 cells may have the potential to contribute to MS pathogenesis. © 2004 Wiley‐Liss, Inc.

[1]  G. Rosati,et al.  Alpha B‐crystallin is not a dominant peripheral T‐cell autoantigen in multiple sclerosis amongst Sardinians , 2003, European journal of neurology.

[2]  M. Gulley,et al.  Clinical applications of BCR-ABL molecular testing in acute leukemia. , 2003, The Journal of molecular diagnostics : JMD.

[3]  H. McFarland,et al.  T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients , 2002, Journal of Neuroimmunology.

[4]  R. Henderson,et al.  Identification of Naturally Processed CD4 T Cell Epitopes from the Prostate-Specific Antigen Kallikrein 4 Using Peptide-Based In Vitro Stimulation1 , 2002, The Journal of Immunology.

[5]  R. Cisterna,et al.  Non-radioactive PCR-SSCP with a single PCR step for detection of inhibitor resistant beta-lactamases in Escherichia coli. , 2002, Journal of microbiological methods.

[6]  J. Ilonen,et al.  HLA class II associated risk and protection against multiple sclerosis—a Finnish family study , 2002, Journal of Neuroimmunology.

[7]  X. Montalban,et al.  Specific Proliferation Towards Myelin Antigens in Patients with Multiple Sclerosis During a Relapse , 2002, Autoimmunity.

[8]  Jorge R. Oksenberg,et al.  The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease , 2001, Science.

[9]  T. Wienker,et al.  Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2. , 2000, Human immunology.

[10]  K. Lundin,et al.  Identification and HLA Restriction of Naturally Derived Th1-Cell Epitopes from the Secreted Mycobacterium tuberculosisAntigen 85B Recognized by Antigen-Specific Human CD4+T-Cell Lines , 2000, Infection and Immunity.

[11]  J. Bajramovic,et al.  Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis , 2000, Journal of Neuroimmunology.

[12]  T. MacRae Structure and function of small heat shock/α-crystallin proteins: established concepts and emerging ideas , 2000, Cellular and Molecular Life Sciences CMLS.

[13]  J. Newcombe,et al.  Presentation of αB-Crystallin to T Cells in Active Multiple Sclerosis Lesions: An Early Event Following Inflammatory Demyelination1 , 2000, The Journal of Immunology.

[14]  P. Travers,et al.  Encephalitogenic and immunogenic potential of the stress protein αB-crystallin in Biozzi ABH (H-2Ag7) mice , 2000, Journal of Neuroimmunology.

[15]  John I. Clark,et al.  Small heat-shock proteins and their potential role in human disease. , 2000, Current opinion in structural biology.

[16]  C. Boog,et al.  Tolerance controls encephalitogenicity of αB-crystallin in the Lewis rat , 2000, Journal of Neuroimmunology.

[17]  L. Fugger,et al.  A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor , 1999, Nature Genetics.

[18]  H. Link,et al.  Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines , 1999, Journal of Neuroimmunology.

[19]  W. Schaper,et al.  Binding of the stress protein alpha B-crystallin to cardiac myofibrils correlates with the degree of myocardial damage during ischemia/reperfusion in vivo. , 1999, Journal of molecular and cellular cardiology.

[20]  M. V. van Stipdonk,et al.  EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. , 1999, Journal of immunology.

[21]  Don C. Wiley,et al.  Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein , 1998, The Journal of experimental medicine.

[22]  T. Olsson,et al.  Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis , 1998, Journal of Neuroimmunology.

[23]  P. Travers,et al.  T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen. , 1998, International immunology.

[24]  H. McFarland,et al.  T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects , 1998, Journal of Neuroimmunology.

[25]  J. Strominger,et al.  HLA-DP2: self peptide sequences and binding properties. , 1997, Journal of immunology.

[26]  A. Ben-nun,et al.  Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions , 1997, European journal of immunology.

[27]  P. Charukamnoetkanok,et al.  Thymic expression of autoantigens correlates with resistance to autoimmune disease. , 1997, Journal of immunology.

[28]  H. Lassmann,et al.  Expression of αB-crystallin in glia cells during lesional development in multiple sclerosis , 1997, Journal of Neuroimmunology.

[29]  L Steinman,et al.  Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.

[30]  C. Goodyer,et al.  Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  C. Melief,et al.  Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells. , 1995, Leukemia.

[32]  C. Polman,et al.  The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis , 1995, Nature.

[33]  H. Rammensee,et al.  Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. , 1994, Journal of immunology.

[34]  C Oseroff,et al.  Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones , 1994, The Journal of experimental medicine.

[35]  P. Kelly,et al.  Oligodendrocyte injury is an early event in lesions of multiple sclerosis. , 1993, Mayo Clinic proceedings.

[36]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[37]  D. Bourdette,et al.  Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.

[38]  L. Ding,et al.  Alpha B-crystallin exists as an independent protein in the heart and in the lens. , 1991, European journal of biochemistry.

[39]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[40]  Eric O Long,et al.  HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. , 1990, Journal of immunology.

[41]  H. Weiner,et al.  T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.

[42]  D. Mitchell,et al.  Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. , 1990, International immunology.

[43]  D. Bourdette,et al.  Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules , 1989, Journal of neuroscience research.

[44]  R. Sobel,et al.  Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. , 1989, Journal of immunology.

[45]  P. Gregersen,et al.  Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. , 1988, Journal of immunology.

[46]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[47]  W. D. de Jong,et al.  The primary structure of the B2 chain of human α‐crystallin , 1977 .

[48]  H. McFarland,et al.  Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. , 1995, Critical reviews in clinical laboratory sciences.